Mitoxantrone Hydrochloride Liposome Injection Combined With Bu/Cy Conditioning on Acute Myeloid Leukaemia Patients With Intermediate/Adverse Risk Disease or Persistently Positive MRD Undergoing Allogeneic Haematopoietic Stem-cell Transplantation: a Prospective, Single-center, Exploratory Clinical Study
Latest Information Update: 12 Jan 2025
Price :
$35 *
At a glance
- Drugs Mitoxantrone liposomal (Primary) ; Busulfan; Cyclophosphamide
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 12 Jan 2025 New trial record